UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000052664
Receipt number R000060097
Scientific Title Evaluation of the usefulness of proton therapy for intracranial tumors using a model-based approach
Date of disclosure of the study information 2023/10/31
Last modified on 2024/10/31 10:00:36

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Multi-institutional study to evaluate the usefulness of proton therapy for intracranial tumors using normal tissue complication probability model

Acronym

MBAPT-CNS trial

Scientific Title

Evaluation of the usefulness of proton therapy for intracranial tumors using a model-based approach

Scientific Title:Acronym

MBAPT-CNS trial

Region

Japan


Condition

Condition

Glioma, Meningioma

Classification by specialty

Radiology Neurosurgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To verify the usefulness of proton therapy by comparing proton beam treatment plan with virtual X-ray treatment plan (intensity modulated radiation therapy, created in Hokkaido university hospital).

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Model based normal tissue complication probability (NTCP) (alopecia, hearing inmairment, tinnitus, cognitive disorder, blindness, cataract, brain necrosis, endocrine dysfunction, second malignancy)

Key secondary outcomes

1. Search for indicators that indicate the validity of plan comparison in planning studies
2. Search for indicators to select patients for whom proton beam therapy is desirable
3. Comparison of actual probability of adverse event occurrence and predicted NTCP (performance evaluation of NTCP model)


Base

Study type

Others,meta-analysis etc


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Among patients with glioma and meningioma who were registered in the proton beam registry database, radiation therapy was started between May 1, 2016 and April 30, 2021, and treatment plan data could be submitted in DICOM format. A person who is capable of outputting information and who has not received a refusal to participate in this research from a research subject or a person who is considered to be able to represent the wishes and interests of the research subject.

Key exclusion criteria

1. Persons of nationality other than Japan
2. Persons who underwent hyperfractionated irradiation (irradiation twice a day)
3. Persons who received proton beam therapy as private practice
4. Persons who have undergone proton beam therapy to areas with a history of radiation therapy
5. Other persons deemed unsuitable as research subjects by the research director

Target sample size



Research contact person

Name of lead principal investigator

1st name Hidefumi
Middle name
Last name Aoyama

Organization

Hokkaido university

Division name

Department of radiation oncology

Zip code

060-8638

Address

Kita 15, Nishi 7, Kita ku, Sapporo, Hokkaido

TEL

011-706-5977

Email

ro-inquiry@ml.hokudai.ac.jp


Public contact

Name of contact person

1st name Kentaro
Middle name
Last name Nishioka

Organization

Hokkaido university

Division name

Global Center for Biomedical Science and Engineering

Zip code

060-8638

Address

Kita 15, Nishi 7, Kita-ku, Sapporo, Hokkaido

TEL

011-706-7798

Homepage URL


Email

k.nishioka@pop.med.hokudai.ac.jp


Sponsor or person

Institute

Hokkaido university

Institute

Department

Personal name

Hidefumi Aoyama


Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

Southern TOHOKU Proton therapy center, University of Tsukuba Hospital, National Cancer Center Hospital East, Aizawa Hospital, Nagoya city university west medical center, Fukui prefectural hospital, Hyogo ion beam medical center, Medipolis Proton Therapy and Research Center, Tsuyama Chuo Hospital, Sapporo Teishinkai hospital, University hospital Kyoto prefectural university of medicine

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethical Review Board for Life Science and Medical Research, Hokkaido University Hospital

Address

Kita 14, Nishi 5, Kita-ku, Sapporo, Hokkaido

Tel

011-706-7636

Email

crjimu@huhp.hokudai.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 10 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

68

Results


Results date posted


Results Delayed

Delay expected

Results Delay Reason

The research has required more time than initially anticipated for presenting findings and publishing results, and an extension of the research period is planned.

Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2023 Year 03 Month 22 Day

Date of IRB

2023 Year 04 Month 11 Day

Anticipated trial start date

2023 Year 04 Month 11 Day

Last follow-up date

2024 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

A virtual X-ray treatment plans are created using images of patients that have undergone proton beam therapy in the past, and the normal tissue complication probability of each treatment will be calculated and compared.


Management information

Registered date

2023 Year 10 Month 31 Day

Last modified on

2024 Year 10 Month 31 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000060097